OBJECTIVE: Male gender, tobacco smoking and occupational exposure to arylamines and polycyclic aromatic hydrocarbons are the primary risk factors for bladder cancer. Emerging, and consistent data indicate that risk may be modified by polymorphisms in carcinogen metabolism genes, including those involving the glutathione-S-transferases. Recent work further suggests that susceptibility to the carcinogenic effects of tobacco on the bladder may differ among men and women. METHOD: We investigated the gender specific risk of bladder cancer associated with glutathione-S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms in a population-based case-control study of 354 bladder cancer cases and 542 controls. RESULTS: We found an increased risk of bladder cancer associated with GSTM1 null genotype among women (OR 1.7; 95% CI 1.0-3.0), but not men (OR 0.9; 95% CI 0.7-1.3). Among women, the GSTM1 null genotype was associated with an elevated bladder cancer risk only among smokers (OR 2.3; 95% CI 1.1-4.5 in ever smokers versus OR 0.9; 95% CI 0.3-2.5 in never smokers). There was no apparent association between bladder cancer and the GSTT1 null polymorphism in either men or women, and we did not detect evidence of any GSTT1-smoking or GSTT1-GSTM1 gene-gene interaction. CONCLUSION: Our data suggest that a subset of women may be particularly susceptible to tobacco-induced bladder cancer.
OBJECTIVE: Male gender, tobacco smoking and occupational exposure to arylamines and polycyclic aromatic hydrocarbons are the primary risk factors for bladder cancer. Emerging, and consistent data indicate that risk may be modified by polymorphisms in carcinogen metabolism genes, including those involving the glutathione-S-transferases. Recent work further suggests that susceptibility to the carcinogenic effects of tobacco on the bladder may differ among men and women. METHOD: We investigated the gender specific risk of bladder cancer associated with glutathione-S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms in a population-based case-control study of 354 bladder cancer cases and 542 controls. RESULTS: We found an increased risk of bladder cancer associated with GSTM1 null genotype among women (OR 1.7; 95% CI 1.0-3.0), but not men (OR 0.9; 95% CI 0.7-1.3). Among women, the GSTM1 null genotype was associated with an elevated bladder cancer risk only among smokers (OR 2.3; 95% CI 1.1-4.5 in ever smokers versus OR 0.9; 95% CI 0.3-2.5 in never smokers). There was no apparent association between bladder cancer and the GSTT1 null polymorphism in either men or women, and we did not detect evidence of any GSTT1-smoking or GSTT1-GSTM1 gene-gene interaction. CONCLUSION: Our data suggest that a subset of women may be particularly susceptible to tobacco-induced bladder cancer.
Authors: Corina Lesseur; Diane Gilbert-Diamond; Angeline S Andrew; Rebecca M Ekstrom; Zhongze Li; Karl T Kelsey; Carmen J Marsit; Margaret R Karagas Journal: Toxicol Lett Date: 2012-01-28 Impact factor: 4.372
Authors: João Paulo Souto Grando; Hellen Kuasne; Roberta Losi-Guembarovski; Iara Sant'ana Rodrigues; Henrique Mitsu Matsuda; Paulo Emílio Fuganti; Emerson Pereira Gregório; Farid Libos Júnior; Rodrigo Paes de Menezes; Marco Aurélio de Freitas Rodrigues; Ilce Mara de Syllos Cólus Journal: Clin Exp Med Date: 2008-11-01 Impact factor: 3.984
Authors: Maree T Brinkman; Margaret R Karagas; Michael S Zens; Alan R Schned; Raoul C Reulen; Maurice P Zeegers Journal: Br J Nutr Date: 2011-05-10 Impact factor: 3.718
Authors: Jay H Lubin; Joshua Muscat; Mia M Gaudet; Andrew F Olshan; Maria Paula Curado; Luigino Dal Maso; Victor Wünsch-Filho; Erich M Sturgis; Neonilia Szeszenia-Dabrowska; Xavier Castellsague; Zuo-Feng Zhang; Elaine Smith; Leticia Fernandez; Elena Matos; Silvia Franceschi; Eleonora Fabianova; Peter Rudnai; Mark P Purdue; Dana Mates; Qingyi Wei; Rolando Herrero; Karl Kelsey; Hal Morgenstern; Oxana Shangina; Sergio Koifman; Jolanta Lissowska; Fabio Levi; Alexander W Daudt; Jose Eluf Neto; Chu Chen; Philip Lazarus; Deborah M Winn; Stephen M Schwartz; Paolo Boffetta; Paul Brennan; Ana Menezes; Carlo La Vecchia; Michael McClean; Renato Talamini; Thangarajan Rajkumar; Richard B Hayes; Mia Hashibe Journal: Cancer Causes Control Date: 2011-07-09 Impact factor: 2.506
Authors: Maree T Brinkman; Margaret R Karagas; Michael Scott Zens; Alan Schned; Raoul C Reulen; Maurice P Zeegers Journal: Cancer Causes Control Date: 2009-12-31 Impact factor: 2.506